A clinical study of docetaxel with or without 5'DFUR as a second-line chemotherapy for advanced gastric cancer.

Maruta, Fukuto; Ishizone, Satoshi; Hiraguri, Manabu; Fujimori, Yoshiro; Shimizu, Fumiaki; Kumeda, Shigeyoshi; Miyagawa, Shinichi

Maruta, Fukuto; Ishizone, Satoshi; Hiraguri, Manabu; Fujimori, Yoshiro; Shimizu, Fumiaki; Kumeda, Shigeyoshi; Miyagawa, Shinichi.

Affiliation

Maruta F; Department of Surgery, Shinshu University School of Medicine, Japan. maruta@hsp.md.shinshu-u.ac.jp

Med Oncol ; 24(1): 71-5, 2007.

Article in En | MEDLINE | ID: mdl-17673814

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Stomach Neoplasms/drug therapy; Aged; Docetaxel; Female; Floxuridine/administration & dosage; Humans; Male; Middle Aged; Pilot Projects; Prognosis; Survival Rate; Taxoids/administration & dosage

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2007 Type: Article

Search on Google

XML

PubMed Links